• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米技术增强型纳洛酮及阿片类药物成瘾的替代疗法

Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction.

作者信息

Heyns Ingrid Marie, Faunce Alina Farah, Mumba Mercy Ngosa, Kumar M N V Ravi, Arora Meenakshi

机构信息

The Center for Convergent Bioscience and Medicine (CCBM), The University of Alabama, Tuscaloosa, Alabama 35401, United States.

Department of Translational Science and Medicine, College of Community Health Sciences, The University of Alabama, Tuscaloosa, Alabama 35401, United States.

出版信息

ACS Pharmacol Transl Sci. 2024 May 27;7(8):2237-2250. doi: 10.1021/acsptsci.4c00158. eCollection 2024 Aug 9.

DOI:10.1021/acsptsci.4c00158
PMID:39144549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11320732/
Abstract

Opioids are commonly prescribed to address intense, ongoing pain associated with cancer, as well as long-lasting noncancer-related pain when alternative methods have proven ineffective. Individuals who exhibit both chronic pain and misuse of opioids face a significant danger of experiencing adverse health outcomes and the potential loss of life related to opioid use. Thus, there is a current movement to prescribe naloxone to those considered high-risk for opioid overdose. Naloxone has been explored as an antidote to reverse acute respiratory depression. Conversely, naloxone can give rise to other problems, including hypertension and cardiac arrhythmias. Thus, the importance of nanotechnology-enabled drug delivery strategies and their role in mitigating naloxone side-effects are significant. In this review, we explore the latest advancements in nanotechnology-enabled naloxone and alternative methods for addressing the opioid crisis through the utilization of non-opioid natural alternatives for chronic pain management.

摘要

阿片类药物通常用于治疗与癌症相关的剧烈、持续性疼痛,以及在其他替代方法被证明无效时治疗长期的非癌症相关疼痛。同时患有慢性疼痛和滥用阿片类药物的个体面临着出现不良健康后果以及因使用阿片类药物而有潜在生命损失的重大风险。因此,目前有一项举措是为那些被认为有阿片类药物过量高风险的人开纳洛酮。纳洛酮已被研究作为一种逆转急性呼吸抑制的解毒剂。相反,纳洛酮会引发其他问题,包括高血压和心律失常。因此,基于纳米技术的药物递送策略的重要性及其在减轻纳洛酮副作用方面的作用意义重大。在这篇综述中,我们探讨了基于纳米技术的纳洛酮的最新进展,以及通过利用非阿片类天然替代品进行慢性疼痛管理来解决阿片类药物危机的替代方法。

相似文献

1
Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction.纳米技术增强型纳洛酮及阿片类药物成瘾的替代疗法
ACS Pharmacol Transl Sci. 2024 May 27;7(8):2237-2250. doi: 10.1021/acsptsci.4c00158. eCollection 2024 Aug 9.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Florida Controlled Substance Prescribing佛罗里达州受管制物质处方开具
4
NP Safe Prescribing of Controlled Substances While Avoiding Drug Diversion安全开具管制药品处方,同时避免药物转移
5
Responsible Controlled Substance and Opioid Prescribing负责任的管制药品和阿片类药物处方开具
6
West Virginia Opioid Prescribing for Chronic Pain While Avoiding Drug Diversion西弗吉尼亚州慢性疼痛的阿片类药物处方开具与避免药物转移
7
Tennessee Controlled Substance Prescribing for Acute and Chronic Pain田纳西州急性和慢性疼痛的受控物质处方
8
Kentucky KASPER and Controlled Substance Prescribing肯塔基州KASPER与管制药品处方
9
Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.阿片类药物安全措施的存在、阿片类药物和纳洛酮的处方模式,以及开具纳洛酮的感知障碍:基于实践类型、范围和地点的横断面调查结果。
J Opioid Manag. 2021 Jan-Feb;17(1):19-38. doi: 10.5055/jom.2021.0611.
10
Vermont Controlled Substance Abuse, Diversion, Storage, Disposal, Monitoring, and Legal Issues佛蒙特州受控物质滥用、转移、储存、处置、监测及法律问题

引用本文的文献

1
Role of Nanomedicine in Transforming Pharmacotherapy for Substance Use Disorder (SUD).纳米医学在改变物质使用障碍(SUD)药物治疗中的作用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Mar-Apr;17(2):e70008. doi: 10.1002/wnan.70008.
2
A temperature-responsive PLA-based nanosponge as a novel nanoadjuvant and efficient delivery carrier of Ag85B for effective vaccine against Mycobacterium tuberculosis.一种基于聚乳酸的温度响应性纳米海绵,作为新型纳米佐剂和Ag85B的高效递送载体,用于制备抗结核分枝杆菌的有效疫苗。
Cell Commun Signal. 2025 Apr 1;23(1):159. doi: 10.1186/s12964-025-02105-2.

本文引用的文献

1
Naloxone-AuNPs@ZIF-8-Based Impedimetric Sensor Platform for Ultrasensitive Detection of Fentanyl and Fabrication of Fen-Track Prototype for Real-Field Analysis.基于纳洛酮-AuNPs@ZIF-8 的阻抗传感器平台用于超灵敏检测芬太尼及 Fen-Track 原型的制备用于现场实际分析
ACS Appl Mater Interfaces. 2024 Jan 10;16(1):190-200. doi: 10.1021/acsami.3c14246. Epub 2023 Dec 28.
2
On-Demand Opioid Effect Reversal with an Injectable Light-Triggered Polymer-Naloxone Conjugate.按需注射型光触发聚合物-纳洛酮缀合物逆转阿片类药物效应。
Nano Lett. 2023 Nov 22;23(22):10545-10553. doi: 10.1021/acs.nanolett.3c03426. Epub 2023 Nov 8.
3
Curcumin attenuates morphine dependence by modulating μ-opioid receptors and glial cell-activated neuroinflammation in rat.姜黄素通过调节大鼠体内的μ-阿片受体和胶质细胞激活的神经炎症来减轻吗啡依赖性。
Neuropeptides. 2023 Apr;98:102318. doi: 10.1016/j.npep.2022.102318. Epub 2022 Dec 29.
4
Nanomedicine-based commercial formulations: current developments and future prospects.基于纳米医学的商业制剂:当前进展与未来展望。
J Pharm Investig. 2023;53(1):19-33. doi: 10.1007/s40005-022-00607-6. Epub 2022 Dec 19.
5
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.美国疾病预防控制中心 2022 年《疼痛阿片类药物处方临床实践指南》。
MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1.
6
Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?关联污名:阿片类药物使用障碍的污名对纳洛酮态度的影响有多大?
J Pharm Pract. 2023 Aug;36(4):941-952. doi: 10.1177/08971900221097173. Epub 2022 May 3.
7
Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport.丁丙诺啡的甘油三酯模拟前药通过促进淋巴转运提高口服生物利用度。
Front Pharmacol. 2022 Apr 12;13:879660. doi: 10.3389/fphar.2022.879660. eCollection 2022.
8
Drug repurposing for stroke intervention.药物再利用治疗中风。
Drug Discov Today. 2022 Jul;27(7):1974-1982. doi: 10.1016/j.drudis.2022.03.003. Epub 2022 Mar 4.
9
Bioactive compounds for neuropathic pain: An update on preclinical studies and future perspectives.用于神经性疼痛的生物活性化合物:临床前研究及未来展望的最新进展
J Nutr Biochem. 2022 Jun;104:108979. doi: 10.1016/j.jnutbio.2022.108979. Epub 2022 Mar 2.
10
Evaluation of Injectable Naloxone-Releasing Hydrogels.可注射释放纳洛酮水凝胶的评估
ACS Appl Bio Mater. 2020 Nov 16;3(11):7858-7864. doi: 10.1021/acsabm.0c01016. Epub 2020 Nov 4.